Skip to main content
. 2014 Sep 1;165(2):325–335. doi: 10.1016/j.trsl.2014.08.006

Table II.

LIPS for antibody detection of infectious agents

Disease/infection Examples of important findings made by LIPS
Strongyloides stercoralis
  • LIPS showed improved serologic test compared with ELISA for S. stercoralis 35, 36

  • Demonstrated utility of evaluating antibody responses for monitoring therapy of S. stercoralis 35

Onchocerca volvulus
  • Improved serologic testing compared with ELISA for Onchocerciasis 31

Loa loa
  • Improved serologic testing compared with ELISA for L. loa infection7

  • Developed high-performance rapid test for L. loa antibodies7

EBV
  • Discovered a unique antibody profile in patients with chronic active EBV49

  • Demonstrated anti-gp350 EBV antibodies detected by LIPS correlated with neutralizing anti-EBV antibodies41

HIV
  • Evaluated antibodies against the HIV proteome using defined recombinant proteins42

  • Discovered unique antibody signature in subset of elite HIV controllers51

  • Obtained evidence for near absence of anti-HIV antibodies in the first person cured, the Berlin patient53

  • Distinguished patients with HIV from blood donor controls based on broad antibody profiles against multiple common infectious agents61

HTLV-1
  • Analyzed antibodies to full HTLV-1 proteome and discovered high levels of anti-envelope antibodies in patients with HTLV-I–associated myelopathy/tropical spastic paraparesis compared with asymptomatic or patients with associated lymphoma48, 52

HCV
  • Identified an antibody profile that correlated with response to treatment in patients infected with HCV-HIV43

Wuchereria bancrofti
  • From screening 16 W. bancrofti proteins for antibodies, identified Wb123 as an early and specific marker for infection45, 64

KSHV
  • Identified v-cyclin as a new robust serologic marker for KSHV infection30

  • Found increased antibody responses against lytic vs latent viral proteins in multicentric Castlemen's disease compared with patients with Kaposi's sarcoma50

NPHV
  • LIPS screening of different animals identified a novel NPHV in horses58

MERS
  • Provided serologic evidence that camels have harbored MERS for more than 20 y60

Abbreviations: EBV, Epstein-Barr virus; ELISA, enzyme-linked immunosorbent assay; HCV, hepatitis C virus; HIV, human immunodeficiency virus; HTLV, human T-lymphotropic virus; LIPS, luciferase immunoprecipitation system; MERS, Middle East respiratory syndrome; NPHV, nonprimate HCV-like virus.